Europe Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast to 2022
Europe Breast Cancer Screening Market Analyst View: Europe Breast Cancer Screening Market will be less than US$ 8 Billion by the end of year 2022. Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. Download full Report: http://www.renub.com/europe-breast-cancer-screening-market-mammography-mri-andultrasound-forecast-to-2022-1097-p.php Europe Breast Cancer Screening Market will be less than US$ 8 Billion by the end of year 2022. Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. So, most of the countries of Europe has adopted or in the process to adopt breast cancer screening in their national cancer screening programs. Mammography screening is most commonly used as breast cancer screening method in Europe.
Germany has the Highest Market Share in Breast Cancer Screening Market, but it will lose its Market Leader Position to United Kingdom in Future Germany is the clear winner in the breast cancer screening market as it has huge women population, advanced healthcare infrastructure and government supported screening programs. Under the programs, all women age between 50-69 years are eligible for free breast cancer screening test in every two years. Under this program eligible woman gets a letter from the regional mammography program center to participate in the breast cancer screening program. Germany will maintain their Dominating Position in Europe Breast Cancer Ultrasound Screening Market Due to strong healthcare expending power and increasing breast cancer awareness among the women, Germany is forecast to hold its dominating place in Europe Breast Cancer Screening Market. Presently, Germany, Italy and Spain are steadily losing their market share on comparison to this all other countries such as United Kingdom, France, Switzerland, Norway and Netherlands ultrasound screening market share is expected to grow in the forecasting period 2017-2022. Europe Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast to 2022 is the 2nd Report published by Renub Research on Breast Cancer Screening Market. The
Š Renub Research LLP
Page 1 of 3